antibody-drug binding technology
Scope
Date
~
-
Shipping & Shipbuilding
HD KSOE teams up with Woodside, MOL on liquid hydrogen carrier
South Korea’s top shipbuilder HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) is gearing up to develop and operate a vessel to ...
Feb 14, 2024 (Gmt+09:00)
-
Electric vehicles
Tesla to showcase Cybertruck in South Korea next week
Tesla Inc., the world’s No. 2 electric vehicle maker, is set to showcase its electric full-size pickup Cybertruck in South Korea, home to its ...
Feb 13, 2024 (Gmt+09:00)
-
Artificial intelligence
LG Elec, Upstage to form partnership for on-device AI
South Korea’s artificial intelligence startup Upstage said on Tuesday it has signed a memorandum of understanding with LG Electronics Inc. to ...
Feb 06, 2024 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1, Hyundai Rotem to team up for Middle East export
South Korea's major defense maker LIG Nex1 Co. announced on Tuesday that it has signed a memorandum of understanding (MOU) with Hyundai Rotem Co. to...
Feb 06, 2024 (Gmt+09:00)
-
Energy
Doosan to supply carbon-free power generation technologies to Thailand
South Korea’s major power plant builder Doosan Enerbility Co. will promote the supply of carbon-free power generation technologies such as car...
Jan 29, 2024 (Gmt+09:00)
-
Electronics
Carrier releases large inverter air conditioner combining AI, inverter tech
Carrier Corp. announced on Monday that it will release a large inverter air conditioner, combining artificial intelligence (AI) and inverter technol...
Jan 29, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai launches world's first mega methanol-fueled container
South Korean shipbuilding giant HD Hyundai Co. marked a major milestone in the maritime industry on January 28, christening the world's first mega m...
Jan 29, 2024 (Gmt+09:00)
-
Batteries
LG Energy to invest in Li-metal battery developer Sion Power
Global lithium-ion battery major LG Energy Solution Ltd. will invest in Sion Power Corp., a US startup holding core patents in lithium-metal battery...
Jan 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Artificial intelligence
Samsung, LG go head-to-head in AI components market
Samsung Electro-Mechanics Co. and LG Innotek Co., two major South Korean suppliers for Apple iPhones, are going head-to-head in the artificial intel...
Jan 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Roche to use Biodyne’s tech for cervical cancer diagnostic kits
Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne...
Jan 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Hyundai, Samsung-backed startups vie for spotlight at CES
LAS VEGAS – At CES, big tech names often take center stage but this is also a dream place for underdogs to become rising stars with unconventi...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Samsung, Harman move in lockstep to advance in-vehicle technology
LAS VEGAS – South Korea’s tech giant Samsung Electronics Co. and its wholly owned US subsidiary Harman International Industries Inc. hav...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Samsung to unveil new Odyssey gaming monitors at CES
Samsung Electronics Co. announced on Wednesday that it will unveil new Odyssey OLED gaming monitors at CES 2024, the world's largest IT and consum...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Mobis' auto parts sweep safety, technology awards
South Korean auto parts maker Hyundai Mobis Co. said Thursday that 10 of its new technologies received or or are finalists for awards from external ...
Dec 28, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)